• FDA Inks Research Collaboration with AnaBios contractpharma
    March 11, 2020
    AnaBios announced a Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA) to study adult human primary cardiomyocytes as a reference for cellular properties and drug-induced effects on cardiac function.
PharmaSources Customer Service